Finding novel antibody targets is time consuming and inefficient. Today’s antibody discovery consists of a variety of tools such as hybridoma, phage, and EBV transformed clones. Each has its own limitations and none guarantee success in finding the novel target of choice. In many cases, months of work are required before knowing if results are yielded.
A perfect workflow for antibody discovery would:
From up to 24 weeks to just 1 day